Followers | 283 |
Posts | 1162 |
Boards Moderated | 0 |
Alias Born | 10/04/2020 |
Thursday, July 29, 2021 11:10:49 AM
Your Post:
The paragraph below from the street insider article is REALLY TSUNAMIC:
"We are optimistic that these initial positive data will lead the way forward into what we hope will be a new generation of immune stimulatory cancer drugs: Orally-available agents that will on the one hand unleash anticancer immune responses and on the other hand directly reprogram cancers rendering them less malignant," said Harry Lander, Ph.D., President and Chief Scientific Officer of Regen. "In parallel, we are continuing gene silencing studies with Santosh Kesari, M.D., Ph.D. in which we are precisely quantifying the correlation between inhibition of NR2F6 and immune stimulation. We believe that by using 2 independent approaches towards the same target, we will be in a position to accelerate clinical implementation and diversify our product pipeline." Dr. Santosh Kesari, a renowned neuro-oncologist who holds a doctorate in molecular biology, is with the John Wayne Cancer Institute at Providence Saint John's Health Center."
------
EXACTLY CORRECT and the underlined above is what I've been saying all along!
We are entering The New Age Of Medicine where previously deadly cancers will be rendered less malignant and in some instances arrested altogether!
THE FUTURE OF MEDICINE & RGBP IS A LEADER IN ALL OF THIS!
We hold the Gold....dont' be fooled by the Criminal Counterfeiting MMs.
Massive buying of RGBP real soon that will include World-Wide buying of this STOCK & massive buying by the Crooked MMs.
I'm look for $1.00 to $2.00 short term Post Pink Current!
Be well and prosper...
"Defo's Morning Briefing" Set to Debut for "GreenliteTV" • GRNL • May 21, 2024 2:28 PM
North Bay Resources Announces 50/50 JV at Fran Gold Project, British Columbia; Initiates NI 43-101 Resources Estimate and Bulk Sample • NBRI • May 21, 2024 9:07 AM
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM
VPR Brands (VPRB) Reports First Quarter 2024 Financial Results • VPRB • May 17, 2024 8:04 AM
ILUS Provides a First Quarter Filing Update • ILUS • May 16, 2024 11:26 AM